YNZ-70797-25423
2 vaccinations
3 coded responses
15 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 210 / MD
- Registered
- 2021-05-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-30
Dose 1 — Janssen/Johnson & Johnson
-
2021-05-24
Registered in v-safe
- 2021-06-29
-
2021-09-30
Survey response — 6 months, dose 1MedDRA: Gallbladder disorder — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit, HospitalizationFree text: Gallbladder issue. Not covid related.MedDRA releases: 2024-11 · check-in free text available
-
2021-09-30
Report sent to call center — 6 months, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2021-10-01
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2021-10-30
Dose 2 — Moderna
- 2021-11-01
- 2021-11-02
- 2021-11-04
- 2021-11-05
- 2021-11-06
- 2021-11-13
-
2021-11-21
Survey response — day 21, dose 2MedDRA: Nasal congestion, Nasopharyngitis, Oropharyngeal pain — Feeling: PoorFree text: Cold. Stuffy nose sore throatMedDRA releases: 2024-11 · check-in free text available
- 2021-11-27
- 2021-12-04
-
2021-12-13
Survey response — day 42, dose 2MedDRA: Cough — Feeling: FairFree text: Cough.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-29
- 2022-05-01
- 2022-10-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-30 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-30 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-09-30 | Successful 2021-10-01 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 9 — 6 months, dose 1
Symptoms: Gallbladder issue. Not covid related.
Release 10 — day 21, dose 2
Symptoms: Cold. Stuffy nose sore throat
Release 10 — day 42, dose 2
Symptoms: Cough.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Gallbladder disorder | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release